Abstract
The parkinsonian variant of multiple system atrophy (MSA-P) can be difficult to differentiate from Parkinson's disease (PD). This Practice Point commentary discusses a multicenter study performed by the European MSA Study Group that sought to determine whether certain clinical features could serve as 'red flags', or warning signs, to assist in the early diagnosis of MSA-P. The study included 57 patients with probable MSA-P and 116 patients with probable PD. The presence of two out of six red-flag categories yielded 98.3% specificity and 84.2% sensitivity for a diagnosis of MSA-P as opposed to PD. In 13 of 17 patients with possible MSA-P who later progressed to probable MSA-P, use of the red-flag categories would have accelerated the diagnosis of probable MSA-P by an average of 15.9 months. Although this study has several limitations, the identified red-flag categories may be useful as supportive criteria in diagnosing probable MSA-P.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gilman S et al. (1998) Consensus statement on the diagnosis of multiple system atrophy: American Autonomic Society and American Academy of Neurology. Clin Auton Res 8: 359–362
Köllensperger M et al. (2007) Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 22: 1771–1776
Vodusek DB (2005) How to diagnose MSA early: the role of sphincter EMG. J Neural Transm 112: 1657–1668
Köllensperger M et al. (2008) Red flags for multiple system atrophy. Mov Disord 23: 1093–1099
Gibb WR and Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatr 51: 745–752
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
CL Gooch has acted as a consultant for Baxter Pharmaceuticals. The other authors declared no competing interests.
Rights and permissions
About this article
Cite this article
Zesiewicz, T., Sullivan, K. & Gooch, C. Red flags to spot the parkinsonian variant of multiple system atrophy. Nat Rev Neurol 4, 596–597 (2008). https://doi.org/10.1038/ncpneuro0881
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0881